Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 145 entries
Sorted by: Best Match Show Resources per page
Reconciling theory and practice: An alternative conceptual framework for understanding payments for environmental services

program design

Corbera E, Kosoy N, Muradian R, Pascual U.
GSID: mIpfx11pStgJ
R Muradian, E Corbera, U Pascual, N Kosoy… - Ecological economics, 2010 - Elsevier

This article provides an alternative and novel theoretical approach to the conceptualization and analysis of payments for environmental services (PES). We devote special emphasis to …

Cite
Muradian, R., Corbera, E., Pascual, U., Kosoy, N., & May, P. H. (2010). Reconciling theory and practice: An alternative conceptual framework for understanding payments for environmental services. Ecological economics, 69(6), 1202-1208.
Muradian, Roldan, et al. "Reconciling theory and practice: An alternative conceptual framework for understanding payments for environmental services." Ecological economics 69.6 (2010): 1202-1208.
Copy Download .nbib Format: MLA
How effective are biodiversity conservation payments in Mexico?

program design

Corbera E, Costedoat S, Ezzine-de-Blas D.
GSID: baj20wNKiwcJ
S Costedoat, E Corbera, D Ezzine-de-Blas… - PloS one, 2015 - journals.plos.org

We assess the additional forest cover protected by 13 rural communities located in the southern state of Chiapas, Mexico, as a result of the economic incentives received through …

Cite
Costedoat, S., Corbera, E., Ezzine-de-Blas, D., Honey-Rosés, J., Baylis, K., & Castillo-Santiago, M. A. (2015). How effective are biodiversity conservation payments in Mexico?. PloS one, 10(3), e0119881.
Costedoat, Sébastien, et al. "How effective are biodiversity conservation payments in Mexico?." PloS one 10.3 (2015): e0119881.
Copy Download .nbib Format: MLA
Equity implications of marketing ecosystem services in protected areas and rural communities: Case studies from Meso-America

case studies

Corbera E, Kosoy N.
GSID: Nq2mBfIpPDUJ
E Corbera, N Kosoy, MM Tuna - Global Environmental Change, 2007 - Elsevier

… The following section outlines the equity implications of our case studies. In each sub-section, a clear-cut distinction is made between the initiatives protecting watershed and carbon forest stocks through protected areas (Guatemala and Belize) and community-based schemes …

Cite
Corbera, E., Kosoy, N., & Tuna, M. M. (2007). Equity implications of marketing ecosystem services in protected areas and rural communities: Case studies from Meso-America. Global Environmental Change, 17(3-4), 365-380.
Corbera, Esteve, Nicolas Kosoy, and Miguel Martinez Tuna. "Equity implications of marketing ecosystem services in protected areas and rural communities: Case studies from Meso-America." Global Environmental Change 17.3-4 (2007): 365-380.
Copy Download .nbib Format: MLA
Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.

JAMA

Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ.
PMID: 27654608
JAMA. 2016 Sep 20;316(11):1211-1212. doi: 10.1001/jama.2016.10542.

No abstract available.

Cite
Stein BD, Sorbero M, Dick AW, et al. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016;316(11):1211-1212doi: 10.1001/jama.2016.10542.
Stein, B. D., Sorbero, M., Dick, A. W., Pacula, R. L., Burns, R. M., & Gordon, A. J. (2016). Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA, 316(11), 1211-1212. https://doi.org/10.1001/jama.2016.10542
Stein, Bradley D, et al. "Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment." JAMA vol. 316,11 (2016): 1211-1212. doi: https://doi.org/10.1001/jama.2016.10542
Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20;316(11):1211-1212. doi: 10.1001/jama.2016.10542. PMID: 27654608; PMCID: PMC5257276.
Copy Download .nbib Format: NLM
Unusual mechanism of complete atrioventricular block following atrial flutter ablation.

HeartRhythm case reports

Georger F, De Roy L, Sorea C, Albenque JP, Boveda S, Belhassen B.
PMID: 28491587
HeartRhythm Case Rep. 2015 Jul 17;1(5):369-372. doi: 10.1016/j.hrcr.2015.06.015. eCollection 2015 Sep.

No abstract available.

Cite
Georger F, De Roy L, Sorea C, et al. Unusual mechanism of complete atrioventricular block following atrial flutter ablation. HeartRhythm Case Rep. 2015;1(5):369-372doi: 10.1016/j.hrcr.2015.06.015.
Georger, F., De Roy, L., Sorea, C., Albenque, J. P., Boveda, S., & Belhassen, B. (2015). Unusual mechanism of complete atrioventricular block following atrial flutter ablation. HeartRhythm case reports, 1(5), 369-372. https://doi.org/10.1016/j.hrcr.2015.06.015
Georger, Frederic, et al. "Unusual mechanism of complete atrioventricular block following atrial flutter ablation." HeartRhythm case reports vol. 1,5 (2015): 369-372. doi: https://doi.org/10.1016/j.hrcr.2015.06.015
Georger F, De Roy L, Sorea C, Albenque JP, Boveda S, Belhassen B. Unusual mechanism of complete atrioventricular block following atrial flutter ablation. HeartRhythm Case Rep. 2015 Jul 17;1(5):369-372. doi: 10.1016/j.hrcr.2015.06.015. eCollection 2015 Sep. PMID: 28491587; PMCID: PMC5419675.
Copy Download .nbib Format: NLM
Bioenergy production and sustainable development: science base for policymaking remains limited.

Global change biology. Bioenergy

Robledo-Abad C, Althaus HJ, Berndes G, Bolwig S, Corbera E, Creutzig F, Garcia-Ulloa J, Geddes A, Gregg JS, Haberl H, Hanger S, Harper RJ, Hunsberger C, Larsen RK, Lauk C, Leitner S, Lilliestam J, Lotze-Campen H, Muys B, Nordborg M, Ölund M, Orlowsky B, Popp A, Portugal-Pereira J, Reinhard J, Scheiffle L, Smith P.
PMID: 28331552
Glob Change Biol Bioenergy. 2017 Mar;9(3):541-556. doi: 10.1111/gcbb.12338. Epub 2016 Mar 23.

The possibility of using bioenergy as a climate change mitigation measure has sparked a discussion of whether and how bioenergy production contributes to sustainable development. We undertook a systematic review of the scientific literature to illuminate this relationship and...

Cite
Robledo-Abad C, Althaus HJ, Berndes G, et al. Bioenergy production and sustainable development: science base for policymaking remains limited. Glob Change Biol Bioenergy. 2016;9(3):541-556doi: 10.1111/gcbb.12338.
Robledo-Abad, C., Althaus, H. J., Berndes, G., Bolwig, S., Corbera, E., Creutzig, F., Garcia-Ulloa, J., Geddes, A., Gregg, J. S., Haberl, H., Hanger, S., Harper, R. J., Hunsberger, C., Larsen, R. K., Lauk, C., Leitner, S., Lilliestam, J., Lotze-Campen, H., Muys, B., Nordborg, M., Ölund, M., Orlowsky, B., Popp, A., Portugal-Pereira, J., Reinhard, J., Scheiffle, L., & Smith, P. (2017). Bioenergy production and sustainable development: science base for policymaking remains limited. Global change biology. Bioenergy, 9(3), 541-556. https://doi.org/10.1111/gcbb.12338
Robledo-Abad, Carmenza, et al. "Bioenergy production and sustainable development: science base for policymaking remains limited." Global change biology. Bioenergy vol. 9,3 (2017): 541-556. doi: https://doi.org/10.1111/gcbb.12338
Robledo-Abad C, Althaus HJ, Berndes G, Bolwig S, Corbera E, Creutzig F, Garcia-Ulloa J, Geddes A, Gregg JS, Haberl H, Hanger S, Harper RJ, Hunsberger C, Larsen RK, Lauk C, Leitner S, Lilliestam J, Lotze-Campen H, Muys B, Nordborg M, Ölund M, Orlowsky B, Popp A, Portugal-Pereira J, Reinhard J, Scheiffle L, Smith P. Bioenergy production and sustainable development: science base for policymaking remains limited. Glob Change Biol Bioenergy. 2017 Mar;9(3):541-556. doi: 10.1111/gcbb.12338. Epub 2016 Mar 23. PMID: 28331552; PMCID: PMC5340281.
Copy Download .nbib Format: NLM
Synthesis and crystal structure of unprecedented phosphine adducts of d(1)-aryl imido-vanadium(IV) complexes.

Inorganic chemistry

Lorber C, Choukroun R, Donnadieu B.
PMID: 12562179
Inorg Chem. 2003 Feb 10;42(3):673-5. doi: 10.1021/ic026089m.

The reaction of the imido precursor [V(NAr)Cl(2)](n)() (1) (Ar = 2,6-i-Pr(2)C(6)H(3)) with 3 equiv of PMe(2)Ph yields the monomeric complex [V(=NAr)Cl(2)(PMe(2)Ph)(2)] (2). Reacting 1 with 1.5 equiv of dmpe or 1 equiv of dppm affords the dimeric complexes [V(=NAr)Cl(2)(dmpe)](2)(mu-P,P'-dmpe)...

Cite
Lorber C, Choukroun R, Donnadieu B. Synthesis and crystal structure of unprecedented phosphine adducts of d(1)-aryl imido-vanadium(IV) complexes. Inorg Chem. 2003;42(3):673-5doi: 10.1021/ic026089m.
Lorber, C., Choukroun, R., & Donnadieu, B. (2003). Synthesis and crystal structure of unprecedented phosphine adducts of d(1)-aryl imido-vanadium(IV) complexes. Inorganic chemistry, 42(3), 673-5. https://doi.org/10.1021/ic026089m
Lorber, Christian, et al. "Synthesis and crystal structure of unprecedented phosphine adducts of d(1)-aryl imido-vanadium(IV) complexes." Inorganic chemistry vol. 42,3 (2003): 673-5. doi: https://doi.org/10.1021/ic026089m
Lorber C, Choukroun R, Donnadieu B. Synthesis and crystal structure of unprecedented phosphine adducts of d(1)-aryl imido-vanadium(IV) complexes. Inorg Chem. 2003 Feb 10;42(3):673-5. doi: 10.1021/ic026089m. PMID: 12562179.
Copy Download .nbib Format: NLM
Synthesis and structure of a series of new d(1)-Aryl imido-vanadium(IV) complexes stabilized by n-donor ligands.

Inorganic chemistry

Lorber C, Choukroun R, Donnadieu B.
PMID: 12160410
Inorg Chem. 2002 Aug 12;41(16):4217-26. doi: 10.1021/ic020312y.

A family of new coordination vanadium(IV) compounds supported by a terminal or bridged aryl imido ligand are reported. Reaction of V(NMe(2))(4) with anilines ArNH(2), where Ar = 2,6-i-Pr(2)-C(6)H(3), 2,6-Me(2)-C(6)H(3), Ph, 2,6-Cl(2)-C(6)H(3), and C(6)F(5), afforded the diamagnetic imido-bridged complexes [V(NAr)(NMe(2))(2)](2)...

Cite
Lorber C, Choukroun R, Donnadieu B. Synthesis and structure of a series of new d(1)-Aryl imido-vanadium(IV) complexes stabilized by n-donor ligands. Inorg Chem. 2002;41(16):4217-26doi: 10.1021/ic020312y.
Lorber, C., Choukroun, R., & Donnadieu, B. (2002). Synthesis and structure of a series of new d(1)-Aryl imido-vanadium(IV) complexes stabilized by n-donor ligands. Inorganic chemistry, 41(16), 4217-26. https://doi.org/10.1021/ic020312y
Lorber, Christian, et al. "Synthesis and structure of a series of new d(1)-Aryl imido-vanadium(IV) complexes stabilized by n-donor ligands." Inorganic chemistry vol. 41,16 (2002): 4217-26. doi: https://doi.org/10.1021/ic020312y
Lorber C, Choukroun R, Donnadieu B. Synthesis and structure of a series of new d(1)-Aryl imido-vanadium(IV) complexes stabilized by n-donor ligands. Inorg Chem. 2002 Aug 12;41(16):4217-26. doi: 10.1021/ic020312y. PMID: 12160410.
Copy Download .nbib Format: NLM
Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics.

Clinical drug investigation

Sorbara C, Armellin G, Bonato R, Callegher L, Giron G.
PMID: 18370558
Clin Drug Investig. 1998;16(6):431-9. doi: 10.2165/00044011-199816060-00003.

OBJECTIVE: This study was designed to investigate the haemodynamic response and pharmacokinetics of a low-dose propofol continuous infusion in providing sedation in patients who required mechanical ventilation after coronary artery bypass grafting surgery.PATIENTS: 22 male patients, aged between 45...

Cite
Sorbara C, Armellin G, Bonato R, et al. Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics. Clin Drug Investig. 1998;16(6):431-9doi: 10.2165/00044011-199816060-00003.
Sorbara, C., Armellin, G., Bonato, R., Callegher, L., & Giron, G. (1998). Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics. Clinical drug investigation, 16(6), 431-9. https://doi.org/10.2165/00044011-199816060-00003
Sorbara, C, et al. "Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics." Clinical drug investigation vol. 16,6 (1998): 431-9. doi: https://doi.org/10.2165/00044011-199816060-00003
Sorbara C, Armellin G, Bonato R, Callegher L, Giron G. Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics. Clin Drug Investig. 1998;16(6):431-9. doi: 10.2165/00044011-199816060-00003. PMID: 18370558.
Copy Download .nbib Format: NLM
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up.

Archives of medical science : AMS

Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C.
PMID: 22427764
Arch Med Sci. 2010 Dec;6(6):900-3. doi: 10.5114/aoms.2010.19299. Epub 2010 Dec 29.

INTRODUCTION: The aim of the study was to investigate at long-term follow-up the incidence of appropriate implantable cardioverter-defibrillator (ICD) shocks and of all-cause mortality in patients with ICDs with ischemic cardiomyopathy versus nonischemic cardiomyopathy.MATERIAL AND METHODS: ICDs were implanted...

Cite
Gandhi K, Aronow WS, Desai H, et al. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up. Arch Med Sci. 2010;6(6):900-3doi: 10.5114/aoms.2010.19299.
Gandhi, K., Aronow, W. S., Desai, H., Amin, H., Lai, H. M., Frishman, W. H., Cohen, M., & Sorbera, C. (2010). Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up. Archives of medical science : AMS, 6(6), 900-3. https://doi.org/10.5114/aoms.2010.19299
Gandhi, Kaushang, et al. "Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up." Archives of medical science : AMS vol. 6,6 (2010): 900-3. doi: https://doi.org/10.5114/aoms.2010.19299
Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up. Arch Med Sci. 2010 Dec;6(6):900-3. doi: 10.5114/aoms.2010.19299. Epub 2010 Dec 29. PMID: 22427764; PMCID: PMC3302702.
Copy Download .nbib Format: NLM
Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride.

Journal of psychopharmacology (Oxford, England)

Giardino L, Calzà L, Piazza PV, Zanni M, Sorbera F, Amato G.
PMID: 22282921
J Psychopharmacol. 1990 Jan;4(1):7-12. doi: 10.1177/026988119000400102.

Anatomical, electrophysiological and pharmacological data support the existence of a pronounced interaction between dopamine (DA) and opioids. In particular, chronic administration of DA antagonist drugs modifies opiate peptides and opiate receptors. In this paper we focused, by means of...

Cite
Giardino L, Calzà L, Piazza PV, et al. Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride. J Psychopharmacol. 1990;4(1):7-12doi: 10.1177/026988119000400102.
Giardino, L., Calzà, L., Piazza, P. V., Zanni, M., Sorbera, F., & Amato, G. (1990). Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride. Journal of psychopharmacology (Oxford, England), 4(1), 7-12. https://doi.org/10.1177/026988119000400102
Giardino, L, et al. "Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride." Journal of psychopharmacology (Oxford, England) vol. 4,1 (1990): 7-12. doi: https://doi.org/10.1177/026988119000400102
Giardino L, Calzà L, Piazza PV, Zanni M, Sorbera F, Amato G. Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride. J Psychopharmacol. 1990 Jan;4(1):7-12. doi: 10.1177/026988119000400102. PMID: 22282921.
Copy Download .nbib Format: NLM
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.

Cancers

Sorber L, Zwaenepoel K, Jacobs J, De Winne K, Goethals S, Reclusa P, Van Casteren K, Augustus E, Lardon F, Roeyen G, Peeters M, Van Meerbeeck J, Rolfo C, Pauwels P.
PMID: 30935089
Cancers (Basel). 2019 Mar 30;11(4). doi: 10.3390/cancers11040458.

The combined analysis of circulating cell-free (tumor) DNA (cfDNA/ctDNA) and circulating cell-free (tumor) RNA (cfRNA/ctRNA) shows great promise in determining the molecular profile of cancer patients. Optimization of the workflow is necessary to achieve consistent and reproducible results. In...

Cite
Sorber L, Zwaenepoel K, Jacobs J, et al. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Cancers (Basel). 2019;11(4)doi: 10.3390/cancers11040458.
Sorber, L., Zwaenepoel, K., Jacobs, J., De Winne, K., Goethals, S., Reclusa, P., Van Casteren, K., Augustus, E., Lardon, F., Roeyen, G., Peeters, M., Van Meerbeeck, J., Rolfo, C., & Pauwels, P. (2019). Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Cancers, 11(4), . https://doi.org/10.3390/cancers11040458
Sorber, Laure, et al. "Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol." Cancers vol. 11,4 (2019). doi: https://doi.org/10.3390/cancers11040458
Sorber L, Zwaenepoel K, Jacobs J, De Winne K, Goethals S, Reclusa P, Van Casteren K, Augustus E, Lardon F, Roeyen G, Peeters M, Van Meerbeeck J, Rolfo C, Pauwels P. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Cancers (Basel). 2019 Mar 30;11(4). doi: 10.3390/cancers11040458. PMID: 30935089; PMCID: PMC6521186.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 145 entries